Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.
Saved in:
| Title: | Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study. |
|---|---|
| Authors: | Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar. hsc2001@qatar-med.cornell.edu.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. hsc2001@qatar-med.cornell.edu., Ayoub HH; Mathematics Program, Department of Mathematics, Statistics and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar., Coyle P; Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK., Tang P; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Hasan MR; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada., Yassine HM; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al Thani AA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kanaani Z; Hamad Medical Corporation, Doha, Qatar., Al-Kuwari E; Hamad Medical Corporation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar., Latif AN; Hamad Medical Corporation, Doha, Qatar., Shaik RM; Hamad Medical Corporation, Doha, Qatar., Abdul-Rahim HF; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Nasrallah GK; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kuwari MG; Primary Health Care Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar., Butt AA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA., Al-Romaihi HE; Ministry of Public Health, Doha, Qatar., Al-Thani MH; Ministry of Public Health, Doha, Qatar., Al-Khal A; Hamad Medical Corporation, Doha, Qatar., Bertollini R; Ministry of Public Health, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Qatar Foundation - Education City, Cornell University, P.O. Box 24144, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2025 Aug 17; Vol. 25 (1), pp. 1028. Date of Electronic Publication: 2025 Aug 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-025-11410-7 |
